Irfanulla Mirza B.’s Post

𝗦𝗲𝘀𝘀𝗶𝗼𝗻 4 𝗮𝘁 𝗖𝗣𝗛𝗜 & 𝗣𝗠𝗘𝗖 𝗜𝗻𝗱𝗶𝗮 2024: 𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗕𝗶𝗼𝘀𝗶𝗺𝗶𝗹𝗮𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗗𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 𝘄𝗶𝘁𝗵 𝗖𝗼𝗻𝗳𝗶𝗱𝗲𝗻𝗰𝗲 The insightful session led by Dr. Dennis McCullough, Vice President of Global Sales at @CAS, just concluded, leaving attendees with a wealth of knowledge about the growing potential of biosimilars and their transformative impact on the pharma industry. Key discussions during the session included: 1. The potential of biosimilars in developing economies: Exploring how these advanced therapeutics can address accessibility and affordability challenges. 2. Understanding biosimilar research: Delving into the complexities of biosimilar development and strategies for effective implementation. 3. Using curated knowledge to accelerate discoveries: Unveiling the power of data-driven insights in driving innovation and enhancing research outcomes in biosimilars. This session was a deep dive into how biosimilars are shaping the future of pharma, offering attendees actionable insights to advance their research and development efforts with confidence. Stay tuned for more highlights from the upcoming sessions as we continue to redefine innovation and collaboration #AtTheHeartOfPharma. #AtTheHeartOfPharma #CPHIIndia #PMECIndia #Biosimilars #PharmaInnovation #PharmaLeadership #KnowledgeSharing Rahul Deshpande, Jayesh Kanaskar, Ketki Karkhanis, Shruti Save, Dheeresh Bangera, Sameer Matkar, Mahesh Verma, Devendra Bhosale, Kanishka Ahuja, Rohan Salian

Come and visit our stand to get a report on the disruptive pre-clinical CROs that are out there - and to discuss M&A and growth strategies should you wish!

𝐀𝐦𝐛𝐢𝐭𝐢𝐨𝐧 𝐌𝐞𝐞𝐭𝐬 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: 𝐒𝐜𝐨𝐭𝐥𝐚𝐧𝐝’𝐬 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐒𝐞𝐜𝐭𝐨𝐫 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐞𝐬 𝐭𝐨 𝐃𝐞𝐥𝐢𝐯𝐞𝐫 Maintaining its impressive end to 2024, Scotland's ecosystem is racking up the wins. We're proud that Edinburgh Technopole and BioCity Glasgow locations are helping to lead the charge. 1️⃣ Ingenza Ltd Secures £2M to Double Capacity Edinburgh Technopole-based biotech leader Ingenza is 𝐝𝐨𝐮𝐛𝐥𝐢𝐧𝐠 𝐢𝐭𝐬 𝐥𝐚𝐛 𝐬𝐩𝐚𝐜𝐞 𝐚𝐧𝐝 𝐜𝐫𝐞𝐚𝐭𝐢𝐧𝐠 𝐭𝐰𝐞𝐧𝐭𝐲 𝐣𝐨𝐛𝐬, fueling Scotland’s pharmaceutical R&D sector. "𝘛𝘩𝘦 𝘱𝘩𝘢𝘳𝘮𝘢𝘤𝘦𝘶𝘵𝘪𝘤𝘢𝘭 𝘙&𝘋 𝘮𝘢𝘳𝘬𝘦𝘵 𝘪𝘴 𝘨𝘳𝘰𝘸𝘪𝘯𝘨 𝘳𝘢𝘱𝘪𝘥𝘭𝘺, 𝘢𝘯𝘥 𝘸𝘦 𝘢𝘳𝘦 𝘸𝘦𝘭𝘭-𝘱𝘰𝘴𝘪𝘵𝘪𝘰𝘯𝘦𝘥 𝘵𝘰 𝘤𝘢𝘱𝘪𝘵𝘢𝘭𝘪𝘴𝘦 𝘰𝘯 𝘵𝘩𝘪𝘴 𝘨𝘳𝘰𝘸𝘵𝘩," Ian Shott, Chair of Ingenza. 👉 https://lnkd.in/eHfPK57m 2️⃣ Cytomos Raises £5M for Groundbreaking Cell Analysis Tech Cytomos, also at Edinburgh Technopole, is expanding its AuraCyt platform to 𝐜𝐮𝐭 𝐝𝐫𝐮𝐠 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐭𝐢𝐦𝐞𝐥𝐢𝐧𝐞𝐬 𝐛𝐲 𝐬𝐢𝐱 𝐦𝐨𝐧𝐭𝐡𝐬 and expand globally. "This investment allows us to scale quickly and support drug development innovation," says CEO David Rigterink. 👉https://lnkd.in/ew4QQX3T 3️⃣ EnteroBiotix Reports Breakthrough Clinical Results BioCity Glasgow-based EnteroBiotix’s Phase 1b study of its EBX-102 microbiome therapy shows 𝐫𝐞𝐦𝐚𝐫𝐤𝐚𝐛𝐥𝐞 𝐦𝐞𝐧𝐭𝐚𝐥 𝐡𝐞𝐚𝐥𝐭𝐡 𝐞𝐟𝐟𝐞𝐜𝐭𝐬 and 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐟𝐨𝐫 𝐥𝐢𝐯𝐞𝐫 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭. "These exciting data strongly support further clinical development." Dr. James McIlroy, CEO of EnteroBiotix. 👉https://lnkd.in/edyu--y7

Easy IMMUNO-ATMPs has come on board as a Media Partner for the 2nd edition of the London Biotechnology Show. Easy IMMUNO-ATMPs!! Immunotherapies and advanced therapies have gained significant relevance in clinical trials due to their potential to revolutionize the treatment of various diseases. This web-page is created to share with you the updates, relevant information, expert interviews highlighting the relevance of immunotherapies and advanced therapies in clinical trials and: -Targeted Treatment -Precision Medicine -Cancer Treatment -Rare Diseases -Regenerative Medicine -Safety and Regulatory Considerations -Market Access and Commercialization -Microbiome -Artificial Intelligence -Inflammation/ Inflammaging -Immuno-oncology. Take advantage of the Early Bird Offer and get Flat 15% OFF on Exhibition and Sponsorship packages. Register today at https://lnkd.in/g_4qGuW9 #lbs #lbs25 #londonbiotechnologyshow #biotechnology #bioinformatics #medtech #innovation #lifesciences #healthcare #pharmaceutical #biomedicalengineering #tissueengineering #biotechconference #biotechevent #biotechexpo #redbiotechnology #excellondon #londonbiotech

How are increased R&D investments driving #innovation in the global culture media market? Increased R&D investments, especially in #lifesciences, are transforming the global culture media market by fueling breakthroughs in drug development and #personalizedmedicine. Innovations like #AI, #genomics, and immunotherapy are reshaping treatment paradigms, enhancing #patientcare across chronic and rare diseases. The #pharmaceutical sector's substantial R&D spending underscores its pivotal role in advancing medical technologies and improving #healthcare outcomes worldwide. Explore more Info : https://lnkd.in/d5d9zvd4 Key Market Players: BD Thermo Fisher Scientific HiMedia Laboratories Pvt. Ltd. FUJIFILM Holdings Corporation Merck & Co., Inc. Corning Incorporated Lonza #RDive #RnDInvestments #LifeScienceInnovation #CultureMediaMarket #DrugDevelopment #PersonalizedMedicine #AIinHealthcare #Genomics #Immunotherapy #HealthcareInnovation

𝐁𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫𝐬 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐚𝐧𝐝 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 Kirti Singh, 𝐏𝐨𝐬𝐭𝐝𝐨𝐜𝐭𝐨𝐫𝐚𝐥 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐬𝐭 𝐚𝐭 Eli Lilly and Company, explores the transformative role of novel biomarkers in clinical trials. With the ability to identify robust biomarkers, researchers are paving the way for innovative treatments for previously incurable diseases. This comprehensive overview discusses various biomarker categories and the challenges faced in biomarker research, shedding light on the evolving landscape of 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐝𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲. Dive into this insightful piece featured in "𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚, 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞 𝟓𝟔," and discover the future of medicine! https://lnkd.in/gzFANYym 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://lnkd.in/dxkGndFf 𝐒𝐭𝐚𝐲 𝐮𝐩𝐝𝐚𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 𝐛𝐲 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐢𝐧𝐠 𝐡𝐞𝐫𝐞: https://lnkd.in/ghDSEXKj 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐨𝐮𝐫 𝐌𝐚𝐠𝐚𝐳𝐢𝐧𝐞 𝐈𝐬𝐬𝐮𝐞𝐬: https://lnkd.in/gAdrmXdF 𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐚𝐝𝐯𝐞𝐫𝐭𝐢𝐬𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚? 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐨𝐮𝐫 𝐦𝐞𝐝𝐢𝐚 𝐩𝐚𝐜𝐤 𝐡𝐞𝐫𝐞: https://lnkd.in/dbaBPC8E #biomarkers #drugdiscovery #clinicaltrials #pharmaceuticals #innovation #research #healthcare #medicalresearch #pharmafocus #pharmafocusasia #medicalinnovation #science #futureofmedicine #biotech #pharmamagazine #articles

Model-informed Drug Development (#MIDD) at #GMP2024 Symposium! ✨   What an incredible experience our ESQlabs GmbH team had at the #GMP2024 Symposium in Lyon, learning, connecting, and sharing some of the insights in #PBPK, #QSP, #qAOP, and disease modeling. 🧬   Key takeaways included the superiority of mechanistic models with #MPS data for accurate human #clearance predictions, insights into #drug metabolism influenced by the gut microbiome, and new strategies for #dose optimization in special #populations. 🔬 We are excited to see the growing interest in using advanced modeling for drug development! 💻   🔎 Curious about what we presented, check out our posters here: https://lnkd.in/eNm2qWCU   🤝 Reach out to us to learn how we're advancing pharmaceutical research. #MIDD #GMP2024 #symposium #PBPK #qAOP #QSP #MPS #networking #innovation #pharmacology

In addition to the keynote at CPHI Middle East this week, our co-founder and CTO Thrasyvoulos Karydis will be on the panel “Exploring AI Potential in Pharma for Drug Discovery and Development" this Thursday, Dec 12. 🧬🧬 Moderated by Dean Calhoun, CIH, President/CEO of Affygility Solutions, with Thras and Majd Abdulghani, PhD, genomics lead at Lean Business Services and Saudi Arabia's first Rhodes Scholar. The panel will delve into the latest developments in AI-driven drug discovery and the impact of artificial intelligence on development timelines, & future possibilities for AI in pharmaceutical innovation collaborative opportunities in the Middle East's growing biotech sector. About CPHI Middle East 2024 CPHI Middle East 2024 will bring together over 400 exhibitors and 30,000 visitors from 100+ countries, focusing on pharmaceutical innovations, networking, and market opportunities in the Middle East. With more than 150 speakers and a backdrop of Saudi Arabia’s rapidly growing pharmaceutical market (projected to reach USD 12.1 billion), this gathering represents a significant opportunity for industry leaders to connect, learn, and drive forward pharmaceutical advancements in the region. More info here: 👇👇 https://lnkd.in/g67VB2fW